Adding ovarian suppression to tamoxifen for pre-menopausal breast cancer
- PMID: 34213458
- DOI: 10.4103/0970-258X.317474
Adding ovarian suppression to tamoxifen for pre-menopausal breast cancer
Conflict of interest statement
None
Comment on
-
Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial.J Clin Oncol. 2020 Feb 10;38(5):434-443. doi: 10.1200/JCO.19.00126. Epub 2019 Sep 16. J Clin Oncol. 2020. PMID: 31518174 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical